What can we do for AMD?

Early, dry AMD does not get the attention it deserves. In fact, it is a topic that many eye care providers do not get too excited about. In my opinion, there are a few reasons why some clinicians are so dispassionate about early AMD, but the two biggest are lack of patient symptoms and a perceived lack of treatment options. Here, I will explain why early AMD deserves more attention and describe what we can do to help patients in a meaningful way.

To begin, AMD is not a small problem that affects only a handful of our patients. On the contrary, in the UK, AMD affects one in 12 patients over age 40, one in six people over age 60, and one in three patients over age 75. This represents more cases than glaucoma and diabetic retinopathy combined.